mRNA Cap 2′-O-Methyltransferase, GMP-Grade (GMP-MEH-VE101), DMF #038029, Accession:
- 产品概述
- 产品规格
- 运输及存储
- 品牌声明
产品概述
产品描述
mRNA Cap 2′-O-Methyltransferase, utilizing S-adenosylmethionine (SAM) as a methyl group donor, adds a methyl group at the 2′-O position of the first nucleotide adjacent to the Cap0 structure at the 5′ end of RNA to obtain m7Gppp5’mN Cap1 structure. Cap1 structure is a signature of self RNA.and has been shown to modulate binding of innate immune sensors. For instance, the binding affinity of IFIT-1 for Cap1 is much weaker than for 5′ triphosphate or Cap0 structure; Cap1 structure abrogates RIG-1 signaling and prevents detection by MDA5. NOTE: Vaccinia Capping Enzyme #GMP-VCS-VE101) is required to generate Cap0 structure. This product has been filed with the FDA Drug Master Files (DMF) and is assigned DMF #038029.
Biotinylated
产品规格
靶点
分子别名
Accession
种属
蛋白序列
分子量
活性
产品标签
表达系统
纯度
内毒素
运输及存储
产品外观
Liquid
运输条件
Shipped with blue ice
制剂
复溶
存储和稳定性
-20±5°C for 24 months. Avoid repeated freeze-thaw cycles.
品牌声明
该产品的品牌ChemWhat是Watson的注册商标,由Watson授权江苏沃尔森在中国大陆地区使用,ChemWhat官方网址.